Defence Therapeutics Inc.
Defence Therapeutics Inc. (DTC.CN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DTC.CN · as of Jun 8, 2026
Key Statistics
Explore Defence Therapeutics Inc. Data
dtc.cn stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
dtc.cn competitorsDTC.CN
ADK.V
BCT.TO
CBST.NE
GLAB.CN
MBX.TOStock Performance
Full HistoryAbout Defence Therapeutics Inc.
Defence Therapeutics Inc. Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cance…
what is defence therapeutics inc. · dtc.cn stock overview · defence therapeutics inc. company profile · who is defence therapeutics inc. ceo · dtc.cn CNQ · defence therapeutics inc. headquarters · defence therapeutics inc. business segments
About Stock Overview & Key Data
Defence Therapeutics Inc. (DTC.CN) is a Healthcare company in the Biotechnology industry, listed on CNQ since May 10, 2021. As of the latest trading session, DTC.CN stock price is $0.50, with a market capitalization of $28.7M. The stock has returned -37.50% over the past 12 months and -30.56% year-to-date.
In fiscal year 2025, Defence Therapeutics Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Defence Therapeutics Inc. (DTC.CN) stock price is $0.50. The stock is traded on CNQ under the ticker symbol DTC.CN. The 52-week range is $0.43 – $0.93.